文献速递MDS 与骨髓增殖性肿瘤

118例骨髓增生异常综合征及相关疾病患者RNA剪接体基因SF3B1、U2AF1和SRSF2的突变分析

[Mutational analysis of RNA splicing machinery genes SF3B1, U2AF1 and SRSF2 in 118 patients with myelodysplastic syndromes and related diseases].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2017-01-01

该研究采用PCR扩增产物直接测序法检测118例MDS及相关疾病患者SF3B1(K700E)、U2AF1(S34、Q157P)和SRSF2(P95)突变,SF3B1突变率19.49%,与环状铁粒幼红细胞增多相关;U2AF1突变率21.90%未见临床特征差异;SRSF2突变率7.48%,突变组初诊年龄偏高。结论认为仅SF3B1突变与环状铁粒幼红细胞密切相关。

要点

  • SF3B1(K700E)突变率19.49%(118例中23例),突变组年龄偏大、血红蛋白偏低、血小板偏高、骨髓原始细胞比例偏低、环状铁粒幼红细胞比例偏高。
  • U2AF1(S34、Q157P)突变率21.90%(105例中23例),突变组各临床特征与未突变组相比差异均无统计学意义。
  • SRSF2(P95)突变率7.48%(107例中8例),突变组初诊中位年龄63(50~84)岁,3例转化为急性髓系白血病。

核心结论

  • SF3B1、U2AF1和SRSF2剪接体复合物蛋白编码基因中,仅SF3B1基因突变与环状铁粒幼红细胞增多性贫血密切相关,是该亚型的主要致病基因。

研究设计与样本

  • 以118例MDS及相关疾病患者为研究对象,采用PCR扩增产物直接测序法分别检测SF3B1(K700E)、U2AF1(S34、Q157P)和SRSF2(P95)突变情况。

主要发现

  • 118例MDS患者中男76例、女42例,中位年龄53.5(13~84)岁;SF3B1(K700E)突变率为19.49%(118例中23例)。
  • 与未突变组相比,SF3B1突变组年龄偏大[58(32~78)岁对51(13~84)岁,z=-1.981,P=0.048]、HGB偏低[63(40~95)g/L对77(34~144)g/L,z=-3.192,P=0.001]、PLT偏高[121(22~888)×10(9)/L对59(6~1 561)×10(9)/L,z=-3.305,P=0.001]、骨髓原始细胞比例偏低[0.007(0~0.122)对0.017(0~0.268),z=-2.885,P=0.004]、RS比例偏高[0(0~64%)对0(0~58%),z=-4.664,P<0.001]。
  • 在突变的22例MDS患者中,14例环形铁粒幼红细胞(RS)比例≥15%,其中RARS 7例、RCMD 6例、RA 1例。
  • 对105例患者进行U2AF1(S34、Q157P)基因突变分析,突变率为21.90%(105例中23例),突变组各临床特征与未突变组相比差异均无统计学意义。
  • 107例患者有SRSF2(P95)突变结果,8例突变,突变率为7.48%,突变组初诊时年龄偏高,中位年龄63(50~84)岁,其中RAEB-1 4例,突变率为14.29%(28例中4例);MDS转化的急性髓系白血病3例。

关键数值与推荐

  • 1例患者同时出现SF3B1(K700E)和SRSF2(P95H)突变,2例患者同时出现SF3B1(K700E)和U2AF1(S34Y)突变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the incidence, molecular features and clinical significance of RNA splicing machinery genes mutation in myelodysplastic syndromes (MDS) and related diseases. Methods: Mutational analysis of splicing factor 3B subunit 1 (SF3B1) (K700E) , U2 small nuclear RNA auxiliary factor 1 (U2AF1) (S34, Q157P) and serine/arginine-rich splicing factor 2 (SRSF2) (P95) in 118, de novo MDS and related diseases were separately performed by using polymerase chain reaction (PCR) followed by sequence analysis. Results: Of 118 MDS patients, 76 males and 42 females, the median age was 53.5 (13-84) years old. 19.49% (23/118) had SF3B1 (K700E) mutation. As compared with those with wild type SF3B1, patients with SF3B1 K700E were of older[58 (32-78) years vs 51 (13-84) years, z=-1.981, P=0.048], lower HGB level[63 (40-95) g/L vs 77 (34-144) g/L, z=-3.192, P=0.001], higher platelet counts[121 (22-888) ×10(9)/L vs 59 (6-1 561) ×10(9)/L, z=-3.305, P=0.001], lower bone marrow blast cell counts[0.007 (0-0.122) vs 0.017 (0-0.268) , z=-2.885, P=0.004], higher ring sideroblasts percent [0 (0-64%) vs 0 (0-58%) , z=-4.664, P<0.001]. Of 105 MDS patients, 21.9% had U2AF1 (S34, Q157P) mutations. Of 107 MDS patients, 8 patients (7.48%) had SRSF2 (P95) mutations. Patients with SRSF2 mutations were older at diagnosis, the median age was 63 (50-84) years old, including 4 cases RAEB-1. The ratio of mutation was 14.29% (4/28) , and three patients transformed to AML. SF3B1 K700E and SRSF2 P95H mutations coexisted in 1 patient, and SF3B1 K700E and U2AF1 S34Y mutations were found concomitantly in 2 patients. Conclusion: Only SF3B1 gene mutation was closely related to ring sideroblasts, it was the key to pathogenesis of MDS. 目的:探讨RNA剪接体复合物编码基因SF3B1、U2AF1和SRSF2突变在MDS及相关疾病中的突变率、突变特点及临床意义。方法:以118例MDS及相关疾病患者为研究对象,采用PCR扩增产物直接测序法分别检测SF3B1(K700E)、U2AF1(S34、Q157P)和SRSF2(P95)突变情况。结果: 118例MDS患者中,男76例,女42例,中位年龄53.5(13~84)岁。对全部患者均进行SF3B1(K700E)基因突变分析,SF3B1(K700E)的突变率为19.49%(118例中23例)。在突变的22例MDS患者中,14例环形铁粒幼红细胞(RS)比例≥15%,其中难治性贫血伴环状铁粒幼红细胞(RARS)7例、难治性血细胞减少伴有多系发育异常(RCMD)6例、难治性贫血(RA)1例。与未突变组相比,突变组患者的年龄偏大[58(32~78)岁对51(13~84)岁,z=-1.981,P=0.048]、PLT偏高[121(22~888)×10(9)/L对59(6~1 561)× 10(9)/L,z=-3.305,P=0.001]、骨髓原始细胞比例偏低[0.007(0~0.122)对0.017(0~0.268),z=-2.885,P=0.004]、RS比例偏高[0(0~64%)对0(0~58%),z=-4.664,P<0.001],HGB偏低[63(40~95)g/L对77(34~144)g/L,z=-3.192,P=0.001]。对105例患者进行U2AF1(S34、Q157P)基因突变分析,突变率为21.90%(105例中23例)。突变组患者各临床特征与未突变组相比差异均无统计学意义。107例患者有SRSF2(P95)突变结果,8例突变,突变率为7.48%,突变组患者初诊时年龄偏高,中位年龄63(50~84)岁,其中难治性贫血伴有原始细胞增多-1(RAEB-1)4例,突变率为14.29%(28例中4例);MDS转化的急性髓系白血病3例。1例患者同时出现SF3B1(K700E)和SRSF2(P95H)突变,2例患者同时出现SF3B1(K700E)和U2AF1(S34Y)突变。结论: SF3B1、U2AF1和SRSF2剪接体复合物蛋白编码基因中,仅SF3B1基因突变与环状铁粒幼红细胞增多性贫血密切相关,是该亚型的主要致病基因。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang JY, Ma J, Lin YN, et al. [Mutational analysis of RNA splicing machinery genes SF3B1, U2AF1 and SRSF2 in 118 patients with myelodysplastic syndromes and related diseases]. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28395441. doi:10.3760/cma.j.issn.0253-2727.2017.03.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。